Review: nanoparticle tools for studying hallmarks of aging
This abstract describes a review of nanoparticle-based tools for detecting, visualizing and fine-tuning hallmarks of aging at the molecular level, linking mechanistic research with translational anti-aging approaches. [1]
Automatic summary · not editorially reviewed
The key findings
The abstract lists aging hallmarks including telomere attrition, cellular senescence and chronic inflammation. [1]
The abstract says conventional genomic, epigenomic, transcriptomic, proteomic and metabolomic tools have a key limitation. [1]
The review is said to present nanoparticle platforms as a toolbox to detect, visualize and fine-tune aging hallmarks. [1]
The source at a glance
- Study type / format
- Review abstract
- Population / context
- Aging biology and age-associated disease, as framed in a review abstract
- Summary based on
- Study abstract
- Original publication
- September 22, 2026
Aging hallmarks and nanoparticle review aim
The abstract describes aging as cumulative damage to genome, proteome, epigenome and organelles, leading to telomere attrition, loss of proteostasis, genomic instability, mitochondrial dysfunction, cellular senescence, altered intracellular communication, chronic inflammation and dysregulated nutrient sensing. It says nanoparticle technologies are changing how these hallmarks can be studied at the molecular level. The stated aim is a comprehensive overview of recent progress on nanoparticles and their applications in the diagnosis and treatment of aging and age-associated disease.
Supporting source [1]
Stated limits of conventional molecular tools
The abstract states that conventional genomic, epigenomic, transcriptomic, proteomic and metabolomic tools have a key limitation. It says nanoparticles therefore play a vital role in the diagnosis and treatment of hallmarks of aging. The review is said to first summarize aging and its hallmarks, then describe different types of molecular tools used in diagnosis of aging and age-associated diseases and their limitations, and finally review applications of each kind of nanoparticle with respect to the hallmarks.
Supporting source [1]
Claimed toolbox role and translational framing
Collectively, the abstract presents nanoparticle platforms as a versatile toolbox to detect, visualize and fine-tune aging hallmarks. It says this connects mechanistic studies with translational anti-aging interventions. These are the review's stated framing and scope; the abstract reports no original measurements, participants, follow-up or effect sizes, and it does not establish that any nanoparticle approach prevents aging or disease in people.
Supporting source [1]
How to interpret this
This is an abstract only; the full text was not reviewed. The abstract reports no original data, study design, sample, follow-up or effect sizes, and it does not show that nanoparticle tools prevent aging or disease in humans.
Based on the study abstract; the full paper, tables and supplementary data were not reviewed.
Source & supporting passages
Yao S, Shen G, Zhao J. · europepmc.org · September 22, 2026